Dear PES Members,
Having just sent a couple messages earlier in the month, I will keep this note brief.
As you know, registration for our Annual Meeting has opened. Please plan to join us in Maryland. In addition to other activities, the meeting will provide us an opportunity to congratulate this year’s PES Laurette Award Winners and Named Lecturers.
Congratulations to:
2025 Judson J Van Wyk Prize: David B. Allen, MD
2025 Senior Investigator Award: Maureen Su, MD
2025 Educator Award: Patricia Vuguin, MD
2025 Clinician Award: Robert Rapaport, MD
2025 New Investigator Award: Laura Jacobsen, MD
2025 Outstanding Mentor Award: Andrew Muir, MD
2025 Blizzard Lecturer: Steve Rosenthal, MD
2025 Kaplowitz Lecturer: Jessica Schmitt, MD
2025 Lawson Wilkins Lecturer: Ursula Kaiser, MD
If you did not read it (or even if you did!), please look back at the January President’s Letter and my goal of celebrating unsung heroes at this year’s Annual Meeting. Please send me a story (can be very short) of someone you think should be celebrated. I need more profiles! (mark.palmert@sickkids.ca with cc to Maureen Thompson at maureen@degnon.org.)
Finally, see below for news and many PES-related activities/opportunities. As always, read all the way to the end; there are many things happening.
Kind Regards,
Mark Palmert, MD
2025 Annual Meeting Registration Now Open!
May 15-18, 2025 – National Harbor, MD
Join us for the 2025 Annual Meeting, happening in person from May 15-18 in National Harbor, MD! This premier event delivers a high-impact program, unparalleled networking opportunities, and a chance to connect with colleagues for professional growth and collaboration.
Experience cutting-edge science through symposia, workshops, spark sessions, year-in-reviews, meet-the-professor sessions, poster presentations, oral abstracts, and more!
Resister here: Pediatric Endocrine Society
PES Pediatric Endocrinology Board Review Course 2025-Registration is Open!
Offered every two years, the PES Board Review Course provides targeted preparation for the Pediatric Endocrinology Boards while also serving as an intensive review for Pediatricians and Adult Endocrinologists.
Click here for more information: Board Review Course – Pediatric Endocrine Society
In Memoriam: Frank S. French, MD
Dr. Frank S. French passed away on February 7th, 2025. Dr. French served as a faculty member and scientist at the University of North Carolina at Chapel Hill from the 1960s through the 2000s. He was one the founders of the division and one of the giants of the pediatric endocrinology field.
Read More: In Memoriam – Frank S. French MD: February 7th, 2025 – Pediatric Endocrine Society
The Biological Reality of Sex and Intersex: A Response to the Executive Order, “Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government”
What is the reason for this Statement?
This Statement responds to the Executive Order, “Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government,” signed by President Trump on January 20, 2025. As leading experts in Pediatric Endocrinology and the biological processes involved in the development of the reproductive tract, we write to provide more complete information on the definition of biological sex. The proposed definitions of biological sex within the Executive Order should not and cannot apply to people born with biological conditions known as Differences of Sex Development (DSD). (Other words used for this group of conditions include: “disorders of sex development”, “variations of sex characteristics”, “variations of sex development”, and “intersex conditions”.)
MAP Spotlight: Eton Pharmaceuticals
Eton Pharmaceuticals is excited to announce that effective December 19, 2024, Increlex® (mecasermin) solution for injection 10mg/ml became part of the Eton Pharmaceuticals portfolio of products. All patient support programs and prescription fulfillment are now managed through Eton Cares. Eton and their specialty pharmacy, AnovoRx, are working closely with the previous pharmacies fulfilling prescriptions to ensure a smooth transition for all patients currently prescribed Increlex. Eton will work to ensure there is no disruption in prescription service for all existing patients. Any new prescriptions must be sent to AnovoRx.
AnovoRx: Phone: 833-343-2500 Fax: 855-813-2039
Eton will immediately begin supporting Increlex patients with our full complement of Eton Cares services. The full range of patient support services include:
Insurance specialists provide personalized assistance and ongoing support to:
- Ensure your patients/caregivers understand their benefits
- Help your office to verify and obtain insurance coverage
- Help the patient/caregiver secure financial assistance for Increlex through the Eton Cares Patient Assistance Program* (*Restrictions, limitations, and/or eligibility requirements may apply.)
- Offer alternative forms of coverage including $0 copay for commercial patients and provide referrals to other sources of financial assistance
Dedicated pharmacists are available 24/7 to provide:
- Patient support by phone
- Worry-free refill reminders
- Shipment alerts
Eton Pharmaceuticals is part of the PES Mission Alliance Partnership. This announcement was prepared in compliance with PES guidelines to ensure objective educational content.
Online Education: Save the dates!
- March 7, 2025- SIG: State of the Art: Transgender Health SIG & EDI Committee
- Session Title: Overview of new and existing research on the mental health impact of hormone therapy for transgender and gender diverse youth
- March 17, 2025- Quarterly Education
- Session Title: Navigating the world of ever-changing treatments for youth-onset type 2 diabetes
- March 20, 2025- SIG: State of the Art: Bone & Mineral SIG
- Session Title: Current and emerging treatments for hypoparathyroidism
- March 28, 2025- SEED
- Session Title: Approach to Diagnosis and Treatment of Youth Onset Diabetes
Visit our education calendar for more information and to register: Events – Pediatric Endocrine Society
New Publishing Opportunity
PES wants members to be aware of a new publishing opportunity. Children now has an endocrinology section for Pediatric Endocrinology and Diabetes with Zvi Laron as Editor-in-Chief. The scope of the Pediatric Endocrinology & Diabetes Section of Children is to help disseminate continuously increasing research into clinical practice. It publishes scholarly, peer-reviewed articles in all areas of Clinical and Experimental Endocrinology, Diabetes, Nutrition, Metabolism, and Genetics.
See (https://www.mdpi.com/journal/children/sections/pediatric_endocrinology) for more information.
Regional meeting invite: PESTOLA Annual Conference
April 4-6, 2025, Irving-Las Colinas, TX
PESTOLA will host its annual regional medical conference on April 4-6, 2025, at the Omni Las Colinas in Irving-Las Colinas, TX. The meeting will be in-person only. A recorded option is available.
TARGET AUDIENCE
Physicians, Trainees, and Nurses with specialties in Academic/Research, Bariatrics, Chronic Disease Prevention, Clinical Research, Community Health, Diabetes, Diabetes Education, Endocrinology, Ethics, General Practice, Genetics, Nutrition and Dietetics, Obesity, Pediatrics and Research.
Community Recipe of the month: Hungarian Palascinta
Health Systems Disparity Spotlight: International Transgender Day of Visibility (TDOV)
Submitted by Jacob Miller, DO, Jax Whitehead, MD
Equity, Diversity and Inclusion Initiative – Pediatric Endocrine Society